Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
MarcS's Profile
Displaying 1051-1100 of 1133 result(s).
CYDY CytoDyn Inc
10/27/2020 12:03:11 AM
Highly doubtful they plan to dilute (3)
CYDY CytoDyn Inc
10/26/2020 11:06:26 PM
UK Info Updated: https://www.clinic (2)
CYDY CytoDyn Inc
10/26/2020 8:47:13 PM
Further, in addition to being CODE (4)
CYDY CytoDyn Inc
10/26/2020 8:42:22 PM
Wrong, these were MARKET purchases. (8)
CYDY CytoDyn Inc
10/26/2020 8:08:45 PM
This is huge. Let's see if there ar
CYDY CytoDyn Inc
10/23/2020 10:57:55 PM
Asking for a 3/4 Review was also no (2)
CYDY CytoDyn Inc
10/23/2020 6:54:13 PM
But what if unblinding and obtainin (5)
CYDY CytoDyn Inc
10/22/2020 6:22:08 PM
It's the special FDA PreCheck line (3)
CYDY CytoDyn Inc
10/22/2020 5:42:02 PM
FDA doubling down on their stupidit (4)
CYDY CytoDyn Inc
10/21/2020 5:32:43 PM
Well, then, they better get serious (4)
CYDY CytoDyn Inc
10/21/2020 5:27:43 PM
It will be one of those grass is gr (3)
CYDY CytoDyn Inc
10/21/2020 5:21:21 PM
It's a 2 in 3 chance of getting ler (2)
CYDY CytoDyn Inc
10/20/2020 9:14:21 AM
I took it as adding a secondary end (4)
CYDY CytoDyn Inc
10/20/2020 5:43:02 AM
Keep trying to post the ZeroHedge a (1)
CYDY CytoDyn Inc
10/20/2020 4:46:35 AM
https://www.zerohedge.com/news/202 (3)
CYDY CytoDyn Inc
10/19/2020 8:01:57 PM
I suppose that's possible. However, (1)
CYDY CytoDyn Inc
10/19/2020 7:04:34 PM
What if there is another announceme (4)
CYDY CytoDyn Inc
10/19/2020 6:45:44 PM
Well, that's very very interesting. (1)
CYDY CytoDyn Inc
10/19/2020 6:34:00 PM
I don't think that site is updated
CYDY CytoDyn Inc
10/19/2020 3:45:47 AM
That isn't the way it works. The tr
CYDY CytoDyn Inc
10/19/2020 1:43:20 AM
Everyone seems to think that a "hal (8)
CYDY CytoDyn Inc
10/18/2020 8:40:42 PM
I'd wondered that myself. It could (1)
CYDY CytoDyn Inc
10/18/2020 7:10:17 PM
No, it was all set that Mexico was (5)
CYDY CytoDyn Inc
10/18/2020 7:07:12 PM
It's like trying to read tea leaves (2)
CYDY CytoDyn Inc
10/18/2020 5:53:14 AM
And, of course it is not accurate a
CYDY CytoDyn Inc
10/16/2020 7:32:45 PM
The real question is whether the "p (1)
CYDY CytoDyn Inc
10/16/2020 10:06:02 AM
They probably sent it to their lawy
CYDY CytoDyn Inc
10/16/2020 2:13:11 AM
The PR is written unduly neutral in (2)
CYDY CytoDyn Inc
10/16/2020 1:22:11 AM
Sorry, but the number of days betwe (2)
CYDY CytoDyn Inc
10/16/2020 12:14:35 AM
Where do you get 6 days? It's only (1)
CYDY CytoDyn Inc
10/15/2020 7:07:16 PM
Interesting analysis. Has anyone el (3)
CYDY CytoDyn Inc
10/15/2020 6:41:19 PM
The last thing you would want to do (2)
CYDY CytoDyn Inc
10/14/2020 1:06:33 AM
He removed more than just leronlima
CYDY CytoDyn Inc
10/14/2020 12:16:41 AM
They already passed the safety look
CYDY CytoDyn Inc
10/14/2020 12:12:48 AM
Well that's good, they can still is
CYDY CytoDyn Inc
10/12/2020 4:53:27 AM
This should be in our favor if Cyto (2)
CYDY CytoDyn Inc
10/11/2020 5:39:43 PM
Mexico wanted CytoDyn to start a cl (2)
CYDY CytoDyn Inc
10/07/2020 4:21:57 PM
JustdInCase Justda wises up and del (2)
CYDY CytoDyn Inc
10/07/2020 3:58:17 PM
Too funny: JustAFart on IHub claime (10)
CYDY CytoDyn Inc
10/07/2020 11:54:52 AM
Looks like they added some. I don't (1)
CYDY CytoDyn Inc
10/07/2020 10:45:11 AM
15.20 - 15.35 A PHASE 2 STUDY OF LE (3)
CYDY CytoDyn Inc
10/07/2020 2:59:23 AM
The shorts use the word "thesis" to (3)
CYDY CytoDyn Inc
10/06/2020 10:13:55 PM
13.5 deaths in the LL group of 130 (4)
CYDY CytoDyn Inc
10/06/2020 5:21:25 PM
Cytodyn posted link to Leronlimab M (2)
CYDY CytoDyn Inc
10/03/2020 6:04:04 PM
He's a media personality with a rea (5)
CYDY CytoDyn Inc
10/03/2020 2:32:55 PM
Michael Savage just tweeted article (14)
CYDY CytoDyn Inc
10/03/2020 1:46:53 PM
Probably the same way we all decide (4)
CYDY CytoDyn Inc
10/03/2020 2:09:49 AM
There were not any clinical trial r (3)
CYDY CytoDyn Inc
10/03/2020 1:33:49 AM
Weird sequence of medications: They (3)
CYDY CytoDyn Inc
10/02/2020 5:47:46 PM
Trump sent to Walter Reed Hospital. (5)
Go to page:
  • << First
  • < Previous
  • 21
  • 22
  • Next >

Recent Articles

  • How to Budget for Hyperbaric Oxygen Therapy
  • Pomerantz Investigates NeoGenomics Amid Securities Concerns
  • Challenges and Triumphs of U.S. Manufacturing Resurgence
  • Exelixis Faces Investigation Over Investor Claims of Fraud
  • Class Action Alert: Novo Nordisk Investors Urged to Act Now
  • Investors May Face Challenges with Lineage, Inc. Stock
  • Legal Investigation Announced for Insperity Investors Amidst Concerns
  • CoreWeave and Other Large-Cap Stocks Accumulate Losses
  • Investor Alert: Class Action Details for XPLR Infrastructure LP
  • Pomerantz Law Firm Pursues Investigation for Neogen Investors
  • Investors Encouraged to Join Class Action Against RxSight, Inc.
  • Easterly ROCMuni Fund Faces Class Action: What Investors Need to Know
  • Supporting Young Drivers: The Cassata Foundation's Initiative
  • Cardboard Shipments Down: What it Signals for the Economy
  • Anticipating the Back-to-School Rush with Innovative Stationery
  • Escape Financial Strain: How Relocating Your Business to a New Market Can Change Everything
  • Empowering Borrowers: RadCred's AI Driven Loan Solutions
  • RadCred's AI-Enhanced Loans Offer Hope for Bad Credit Borrowers
  • Exploring the Economic Landscape: Key Market Insights and Trends
  • Blizzard Entertainment Faces Lawsuit Over Employee Rights Violations
  • Apple Reveals Future Product Developments in Code Leak
  • Lyft's Age Verification Efforts for Citi Bike Riders: Impact
  • Investing Insights: Top Performing Stocks and Market Gains
  • Lyft Implements Age Verification for Electric Bike Riders
  • Opportunities for Hims & Hers Health Inc. Investors Amid Legal Battles
  • Consumer Tech Update: Market Adjustments and Earnings Highlights
  • Recent Developments in Tech: Intel and Nvidia Opportunities
  • GayVeteransUS-Inc Launches Support for Tennessee LGBTQ Veterans
  • Mark Cuban Contemplates Run as Trump Eyeing Third Term
  • Walmart Set for Success While Target Faces Challenges Ahead
  • Urgent Legal Steps for Hims & Hers Health Investors Ahead
  • GenScript Biotech's Impressive Growth and Sustainable Innovations
  • Bitcoin Soars Amid Federal Reserve's Optimism, Gaetz's Token Spotlights
  • Sable Offshore Corp Investors: Important Class Action Insights
  • GenScript Biotech's Exceptional Growth and Future Prospects
  • Acquire.Fi Aids Omni in Strategic Acquisition of Web3 Wallet
  • Pending Class Action for RxSight, Inc. Investors Highlights Risks
  • Understanding the Recent Simulations Plus Securities Investigation
  • Legal Action Update for Sarepta Therapeutics Investors
  • Investigation into J.M. Smucker Co. Raises Concerns for Investors
  • Innovative Moves by Tesla, Ford, and BYD in the EV Space
  • High-Stakes Investor Moves in Healthcare and Tech Sector
  • Air Canada Resumes Flights After Government Arbitration Ruling
  • Cory Thompson Announces Scholarship for Aspiring Leaders
  • Vittori's Exciting Collaboration for Advanced 3D Titanium Parts
  • Exciting Travel Offers from Travelzoo for Adventurous Travelers
  • Lianyungang's Transformation: A Gateway for Global Trade
  • Challenges of Manufacturing Smartphones in America Explored
  • Air Canada Faces Flight Operations Suspension Amid Negotiation
  • Centene Corporation Class Action Lawsuit: What Investors Need to Know
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site